Preclinical research shows that the combination of two existing drugs can exploit the metabolic'hunger' of a particularly aggressive type of neuroblastoma to kill cancer cells without inflicting too much collateral damage to healthy tissue.
Bespoke neuroblastoma therapy weaponizes cell metabolism
- ScienceDaily
- 2. 4 2021 (22:29)